Bionik Laboratories Corp.
BNKL · OTC
3/31/2023 | 12/31/2022 | 9/30/2022 | 6/30/2022 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$1,356 | -$1,076 | -$1,129 | -$1,384 |
| Dep. & Amort. | $20 | $20 | $12 | $11 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $238 | $31 | $55 | $52 |
| Change in WC | $287 | $482 | $89 | $155 |
| Other Non-Cash | $54 | $30 | $17 | $3 |
| Operating Cash Flow | -$757 | -$513 | -$955 | -$1,162 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$1 | $50 | $50 | $0 |
| Net Acquisitions | -$215 | $0 | -$0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $215 | -$51 | -$272 | $0 |
| Investing Cash Flow | -$1 | -$1 | -$222 | $0 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $500 | $800 | $250 | $500 |
| Stock Issued | $0 | $0 | $0 | $0 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $0 | $0 | $0 |
| Financing Cash Flow | $500 | $800 | $250 | $500 |
| Forex Effect | -$0 | $1 | -$4 | -$0 |
| Net Chg. in Cash | -$258 | $287 | -$931 | -$663 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $685 | $398 | $1,329 | $1,991 |
| End Cash | $427 | $685 | $398 | $1,329 |
| Free Cash Flow | -$758 | -$463 | -$905 | -$1,162 |